Catalyst Wire Dossier Catalyst Wire Dossier

Intrinsic Antitachycardia Pacing (iATP) Post-Approval Study (PAS)

· Medtronic
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Intrinsic Antitachycardia Pacing (iATP) Post-Approval Study (PAS), covering 2025-10-20 to 2025-10-20. Get the full timeline:

Most recent: Clinical Trial Update: Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)

See pricing